Vascular Regenerative Cell Deficiencies in South Asian Adults
Aishwarya Krishnaraj(St. Michael's Hospital), Subodh Verma(St. Michael's Hospital), Irene N. Firoz(St. Michael's Hospital), C. David Mazer(St. Michael's Hospital), Basel Bari(Custom Security Industries (Canada)), Hwee Teoh(St. Michael's Hospital), Bobby Yanagawa(St. Michael's Hospital), Ehab Bakbak(St. Michael's Hospital), Arjun Pandey(University of Ottawa), Kim A. Connelly(St. Michael's Hospital), David A. Hess(Western University), Darren K. McGuire(Parkland Health & Hospital System), Daniella C. Terenzi(St. Michael's Hospital), Adrian Quan(St. Michael's Hospital), S. Padanilathu Kunjummar, Yi Pan(St. Michael's Hospital), Raj Verma(Royal College of Surgeons in Ireland), Ori D. Rotstein(St. Michael's Hospital), Asaad I. Bakbak(Lakeridge Health), Deepak L. Bhatt(Mount Sinai Hospital)
Cited by 12
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k